Orifarm
is a provider of medical products such as prescription drugs and capsules for pharmacies and hospitals... Read moreOrifarm
is a provider of medical products such as prescription drugs and capsules for pharmacies and hospitals... Read more
News
Sep 27, 2024
Global Legal Chronicle
Orifarm: Orifarm's Investment Round
Feb 26, 2024
Royal Pharmaceutical Society
Orifarm: Class 4 Medicines Defect Information: Orifarm UK Ltd, Concerta XL 18mg & 36 mg prolonged release tablets
Apr 01, 2021
PharmaLeaders
Orifarm Group A/S: Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m
May 08, 2020
Global Legal Chronicle
Orifarm: Orifarm's $670 Million Acquisition Of Takeda Portfolio
Apr 28, 2020
Biospectrum Asia
Orifarm: Takeda inks deal worth $670M with Orifarm, Read more
Apr 27, 2020
Pharamceutical Technology
Orifarm: Takeda-Orifarm deal: another divestiture for the Japanese pharma giant
Jan 19, 2020
BioPortfolio
Orifarm: Orifarm Group AS Strategic SWOT Analysis Review Published by Global Data Prices from USD $106
Sep 11, 2017
BriefingWire
Press Release: Orifarm : Cholelithiasis Global Clinical Trials Review H1 2017
Sep 04, 2015
PR-INSIDE.COM
Press Release: Orifarm : "Orifarm Group AS - Strategic SWOT Analysis Review" Published
Apr 05, 2015
PR-INSIDE.COM
Press Release: Orifarm : Orifarm Group A/S in Consumer Health (Denmark) - New Market Report
Orifarm Competitors
1
2
3
4
5
6
7
8
9
10